NEURALA BIOSCIENCES
Who is NEURALA BIOSCIENCES?
We develop innovative pharmaceutical grade DMT-based medicines and therapies aiming to transform the lives of those facing some of the most prolific and insidious mental illnesses
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2022 (4 years)
Address:
700 SWANSTON ST; CARLTON , VIC 3053, AU
Employees by Department
- IT / Product (1)
- The Rest (3)
- Total (4)
Key Decision Makers
Daniel Perkins
CEO
Mathew Lehrner
Project Support and Coordination Manager
Anna Urokohara
R&D Project Manager
Jerome Sarris
Co-Founder & Chief Scientific Officer at Neurala Biosciences
Employees by Seniority
C-level
2employees
Senior
0employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has NEURALA BIOSCIENCES been operating for?
- What is the funding status of NEURALA BIOSCIENCES?
- Where is NEURALA BIOSCIENCES's headquarter?
- What NEURALA BIOSCIENCES's spending power?
- Does NEURALA BIOSCIENCES have a presence in the domain it operates in?